This paper presents a new system architecture for controlling industrial devices using Mixed Reality (MR) applications and a new method based upon them for measuring the distance between real and virtual points. The research has been carried out using a physical robot and its Digital Twin (DT). The possibility of controlling them using gestures recognized by Mixed Reality goggles has been presented. The extension of the robot’s environment with a 3D model capable of following its movements and positions was also analyzed. The system was supervised by an industrial Programmable Logic Controller (PLC) serving as an end point for the data sent by the goggles and controlling the movements of the real robot by activating the corresponding control. The results of the preliminary measurements presented here concerned the responsiveness of the system and showing the influence of system parameters in the accuracy of distance estimation between measured points.
Comprehensive epidemiologic data for multiple sclerosis (MS) in Poland are limited. The aim of this cross-sectional population-based study was to determine the incidence and prevalence of MS in the Swietokrzyskie Region (central Poland). This study identified MS cases every year between 1 January 2010 and 31 December 2014. The study area population on the prevalence day (December 31, 2014) was 1,263,176 (646,506 women and 616,670 men). A total of 1462 patients with a clinically definite diagnosis of MS according to McDonald’s criteria (2005), recorded in the Polish Multiple Sclerosis Registry, were considered for estimation of crude, age- and sex-specific prevalence, and incidence. The overall crude prevalence rate of confirmed MS patients was 115.7/100,000 (95 % confidence interval (CI), 111.2–121.4). A significantly higher prevalence was recorded in females (159.6/100,000; 95 % CI, 151.1–165.3) than in males (69.7/100,000; 95 % CI, 62.4–77.3) (P < 0.001). Age-adjusted rates for the Polish and European Standard Population were 109.8/100,000 (95 % CI, 105.4–114.8) and 106.6/100,000 (95 % CI, 101.1–111.2), respectively. The female/male ratio was 2.4. The mean annual incidence was 4.2/100,000 (95 % CI. 3.7–4.4). The incidence and prevalence of MS in the Swietokrzyskie region confirm that central Poland is a high risk area for MS. Compared with previous epidemiologic studies from Poland, the prevalence of MS has increased during recent years.
1 November 2022 in Advances in Science and Technology Research Journal
The concept of Industry 4.0 has now become a fact. One of its key technological solutions – the digital twin – serves as a bridge between the real and virtual worlds. Designs for both products and tools to make these products are generated in the virtual world. Thanks to the simulation...
1 August 2019 in Multiple Sclerosis and Related Disorders
The design of a glazing package containing heating glass can make a window a radiator simultaneously. For such bulky glass to act as an effective radiator simultaneously, it should be possible to provide a constant temperature over the entire surface. The continuous surface temperature of the glass depends on the uniformity of the surface resistance of the resistive layer. This paper will demonstrate the testing of heating glass parameters using a specialised apparatus. The research will mainly focus on measuring the value and distribution of the surface resistance of the transparent heating layer. A thermographic study will verify the results. As the heating glass will be subjected to a toughening process, the effect of the toughening process parameters on the degradation of the transparent heating film will be investigated.
Background: Despite growing evidence supporting the efficacy of dupilumab in the treatment of chronic rhinosinusitis with nasal polyps (CRSwNP), studies directly comparing biologic therapy with revision endoscopic sinus surgery remain limited. This study aimed to compare the effectiveness of dupilumab and revision endoscopic sinus surgery (ESS) in patients with recurrent CRSwNP. Methods: A retrospective cohort study was conducted in 50 patients with CRSwNP who had previously undergone at least two endoscopic sinus surgeries. Twenty-three patients received dupilumab, while twenty-seven underwent revision surgery. Changes in Nasal Polyp Score (NPS), quality of life assessed using the Sino-Nasal Outcome Test-22 (SNOT-22), and olfactory function evaluated with the Sniffin’ Sticks test were analyzed. Final clinical outcomes and the proportion of patients achieving very good disease control were also assessed. Results: Both treatment modalities improved disease control. However, dupilumab was associated with significantly greater reductions in NPS (median [IQR]: −6.00 [−6.00 to −5.00] vs. −4.00 [−6.00 to −3.00]; p = 0.012), larger improvements in SNOT-22 scores (−59.39 ± 12.14 vs. −21.37 ± 20.15; p < 0.001), and better recovery of olfactory function (+4.65 ± 2.79 vs. +2.19 ± 2.08; p = 0.001) compared with revision surgery. Analysis of final outcomes also favored dupilumab, with lower NPS scores (median [IQR]: 0.00 [0.00–1.00] vs. 1.00 [0.00–2.50]; p = 0.023), and better olfactory function (7.65 ± 3.11 vs. 4.78 ± 2.34; p < 0.001). Very good symptom control (SNOT-22 < 20) was achieved by 82.6% of patients treated with dupilumab compared with 7.4% of those undergoing revision surgery. Conclusions: Both revision surgery and dupilumab improved disease control in patients with CRSwNP. In this cohort, dupilumab was associated with greater reductions in disease severity, superior quality-of-life outcomes, and better olfactory function than revision endoscopic sinus surgery.